We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGDV icon
176
Capital Group Dividend Value ETF
CGDV
$38.9B
$152M 0.1%
4,670,048
+545,619
+13% +$16.8M
XLU icon
177
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$152M 0.1%
4,622,074
+442,854
+11% +$13.8M
NKE icon
178
Nike
NKE
$62B
$150M 0.1%
1,599,771
-37,068
-2% -$3.77M
BDX icon
179
Becton Dickinson
BDX
$48.6B
$150M 0.1%
605,284
+42,202
+7% +$10.1M
AXP icon
180
American Express
AXP
$228B
$149M 0.1%
653,725
+5,780
+0.9% +$1.2M
GILD icon
181
Gilead Sciences
GILD
$165B
$149M 0.1%
2,031,209
-452,231
-18% -$34.8M
IVE icon
182
iShares S&P 500 Value ETF
IVE
$49.9B
$146M 0.1%
780,598
-1,048
-0.1% -$186K
TFC icon
183
Truist Financial
TFC
$63.5B
$145M 0.1%
3,709,998
+68,746
+2% +$2.51M
CGGO icon
184
Capital Group Global Growth Equity ETF
CGGO
$11.9B
$144M 0.1%
4,998,845
+475,294
+11% +$12.9M
DGRO icon
185
iShares Core Dividend Growth ETF
DGRO
$43.6B
$143M 0.1%
2,470,630
-43,374
-2% -$2.41M
KKR icon
186
KKR & Co
KKR
$93.1B
$143M 0.1%
1,423,400
+427,844
+43% +$39.3M
DXCM icon
187
DexCom
DXCM
$33.2B
$143M 0.1%
1,031,700
+853,743
+480% +$107M
IEI icon
188
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$143M 0.1%
1,233,872
-21,881
-2% -$2.54M
QUAL icon
189
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$140M 0.09%
852,045
-19,278
-2% -$3.01M
ITW icon
190
Illinois Tool Works
ITW
$84.1B
$140M 0.09%
521,354
+5,932
+1% +$1.54M
RSG icon
191
Republic Services
RSG
$65.8B
$139M 0.09%
726,995
-156
-0% -$27.7K
UL icon
192
Unilever
UL
$135B
$139M 0.09%
2,462,051
+101,787
+4% +$5.64M
BND icon
193
Vanguard Total Bond Market
BND
$161B
$139M 0.09%
1,913,614
+205,916
+12% +$14.9M
EQIX icon
194
Equinix
EQIX
$103B
$139M 0.09%
167,848
-8,116
-5% -$6.83M
ELV icon
195
Elevance Health
ELV
$86.3B
$137M 0.09%
263,805
+14,161
+6% +$7.04M
MAR icon
196
Marriott International
MAR
$90.1B
$137M 0.09%
542,064
-14,153
-3% -$3.43M
NOC icon
197
Northrop Grumman
NOC
$82.4B
$136M 0.09%
284,370
+18,097
+7% +$8.33M
SBUX icon
198
Starbucks
SBUX
$120B
$136M 0.09%
1,485,467
-5,641
-0.4% -$525K
VRTX icon
199
Vertex Pharmaceuticals
VRTX
$134B
$133M 0.09%
318,757
-23,660
-7% -$10M
FDX icon
200
FedEx
FDX
$76.7B
$133M 0.09%
457,518
-66,564
-13% -$16.7M

Similar funds

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.